Inspired by industry trends and demand, the Master of Supply Chain Analytics program at Rutgers Business School will prepare you to be a data-driven decision-maker in a rapidly growing job market. The ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...